Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Postoperative Pain in Endometriosis
NCT05229653Phase 1Terminated
- Sponsor
- NYU Langone Health
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in postoperative pain comparing Low-Dose Ketamine with Placebo (2 arms). Primary endpoint: Pelvic Pain Score on Visual Analogue Scale (VAS). Started Apr 2022; status: terminated.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05229653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229653.